| Yarini Quezada, MD | |
|
5401 Old York Rd Bldg Suite410, Philadelphia, PA 19141-3030 | |
| (215) 456-6990 | |
| (215) 456-6967 |
| Full Name | Yarini Quezada |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 17 Years |
| Location | 5401 Old York Rd Bldg Suite410, Philadelphia, Pennsylvania |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083875652 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Einstein Medical Center Montgomery | East norriton, PA | Hospital |
| Albert Einstein Medical Center | Philadelphia, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Unlv Medicine | 4183991458 | 145 |
| Einstein Practice Plan Inc | 2769395896 | 591 |
News Archive
Accelerated partial breast irradiation was designed to be a faster, more convenient, and potentially safer way for many women with breast cancer to reduce their mortality risk and help keep their cancer from returning after surgery. But a new study shows that the availability of the approach is failing to reduce the percentage of early-stage breast cancer patients who do not receive the radiation treatment that could save their lives.
The California Association of Marriage and Family Therapists (CAMFT) is in full support of the U.S. Supreme Court's ruling that guarantees same-sex couples the right to marry. CAMFT firmly believes that all couples and all families, regardless of sexual orientation or gender identity, should have the civil right to marry, with all the associated privileges and responsibilities.
An illuminating study compares the willingness of stage IV cancer patients, and their caregivers; to pay to extend their lives by one year against that of other end-of-life improvements.
Aptus Endosystems, Inc., a medical device company developing advanced technology for endovascular aneurysm repair (EVAR), announced today that it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the Aptus EndoStapling System, which will now be known as the HeliFX™ Aortic Securement System.
Fluxion Biosciences, Inc. announced today that a lawsuit alleging patent infringement had been filed against it in the US District Court of Northern California by Cellectricon AB, its competitor in the field of automated ion channel screening systems for drug discovery. Cellectricon has asserted U.S. Patents Nos. 7,390,650, 7,470,518, and 7,563,614 in the litigation, as well as U.S. Patent No. 5,376,252, which is owned by Gyros and licensed to Cellectricon.
› Verified 3 days ago
| Entity Name | Healthcare Partners Medical Group Coats Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1487631917 PECOS PAC ID: 5991866303 Enrollment ID: O20100113000898 |
News Archive
Accelerated partial breast irradiation was designed to be a faster, more convenient, and potentially safer way for many women with breast cancer to reduce their mortality risk and help keep their cancer from returning after surgery. But a new study shows that the availability of the approach is failing to reduce the percentage of early-stage breast cancer patients who do not receive the radiation treatment that could save their lives.
The California Association of Marriage and Family Therapists (CAMFT) is in full support of the U.S. Supreme Court's ruling that guarantees same-sex couples the right to marry. CAMFT firmly believes that all couples and all families, regardless of sexual orientation or gender identity, should have the civil right to marry, with all the associated privileges and responsibilities.
An illuminating study compares the willingness of stage IV cancer patients, and their caregivers; to pay to extend their lives by one year against that of other end-of-life improvements.
Aptus Endosystems, Inc., a medical device company developing advanced technology for endovascular aneurysm repair (EVAR), announced today that it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the Aptus EndoStapling System, which will now be known as the HeliFX™ Aortic Securement System.
Fluxion Biosciences, Inc. announced today that a lawsuit alleging patent infringement had been filed against it in the US District Court of Northern California by Cellectricon AB, its competitor in the field of automated ion channel screening systems for drug discovery. Cellectricon has asserted U.S. Patents Nos. 7,390,650, 7,470,518, and 7,563,614 in the litigation, as well as U.S. Patent No. 5,376,252, which is owned by Gyros and licensed to Cellectricon.
› Verified 3 days ago
| Entity Name | Unlv Medicine |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1407397235 PECOS PAC ID: 4183991458 Enrollment ID: O20170517002454 |
News Archive
Accelerated partial breast irradiation was designed to be a faster, more convenient, and potentially safer way for many women with breast cancer to reduce their mortality risk and help keep their cancer from returning after surgery. But a new study shows that the availability of the approach is failing to reduce the percentage of early-stage breast cancer patients who do not receive the radiation treatment that could save their lives.
The California Association of Marriage and Family Therapists (CAMFT) is in full support of the U.S. Supreme Court's ruling that guarantees same-sex couples the right to marry. CAMFT firmly believes that all couples and all families, regardless of sexual orientation or gender identity, should have the civil right to marry, with all the associated privileges and responsibilities.
An illuminating study compares the willingness of stage IV cancer patients, and their caregivers; to pay to extend their lives by one year against that of other end-of-life improvements.
Aptus Endosystems, Inc., a medical device company developing advanced technology for endovascular aneurysm repair (EVAR), announced today that it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the Aptus EndoStapling System, which will now be known as the HeliFX™ Aortic Securement System.
Fluxion Biosciences, Inc. announced today that a lawsuit alleging patent infringement had been filed against it in the US District Court of Northern California by Cellectricon AB, its competitor in the field of automated ion channel screening systems for drug discovery. Cellectricon has asserted U.S. Patents Nos. 7,390,650, 7,470,518, and 7,563,614 in the litigation, as well as U.S. Patent No. 5,376,252, which is owned by Gyros and licensed to Cellectricon.
› Verified 3 days ago
| Entity Name | Intermountain Medical Holdings Nevada Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1245997279 PECOS PAC ID: 7416054622 Enrollment ID: O20220214001765 |
News Archive
Accelerated partial breast irradiation was designed to be a faster, more convenient, and potentially safer way for many women with breast cancer to reduce their mortality risk and help keep their cancer from returning after surgery. But a new study shows that the availability of the approach is failing to reduce the percentage of early-stage breast cancer patients who do not receive the radiation treatment that could save their lives.
The California Association of Marriage and Family Therapists (CAMFT) is in full support of the U.S. Supreme Court's ruling that guarantees same-sex couples the right to marry. CAMFT firmly believes that all couples and all families, regardless of sexual orientation or gender identity, should have the civil right to marry, with all the associated privileges and responsibilities.
An illuminating study compares the willingness of stage IV cancer patients, and their caregivers; to pay to extend their lives by one year against that of other end-of-life improvements.
Aptus Endosystems, Inc., a medical device company developing advanced technology for endovascular aneurysm repair (EVAR), announced today that it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the Aptus EndoStapling System, which will now be known as the HeliFX™ Aortic Securement System.
Fluxion Biosciences, Inc. announced today that a lawsuit alleging patent infringement had been filed against it in the US District Court of Northern California by Cellectricon AB, its competitor in the field of automated ion channel screening systems for drug discovery. Cellectricon has asserted U.S. Patents Nos. 7,390,650, 7,470,518, and 7,563,614 in the litigation, as well as U.S. Patent No. 5,376,252, which is owned by Gyros and licensed to Cellectricon.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Yarini Quezada, MD 101 E Olney Ave Ste 400, Philadelphia, PA 19120-2470 Ph: (215) 456-1825 | Yarini Quezada, MD 5401 Old York Rd Bldg Suite410, Philadelphia, PA 19141-3030 Ph: (215) 456-6990 |
News Archive
Accelerated partial breast irradiation was designed to be a faster, more convenient, and potentially safer way for many women with breast cancer to reduce their mortality risk and help keep their cancer from returning after surgery. But a new study shows that the availability of the approach is failing to reduce the percentage of early-stage breast cancer patients who do not receive the radiation treatment that could save their lives.
The California Association of Marriage and Family Therapists (CAMFT) is in full support of the U.S. Supreme Court's ruling that guarantees same-sex couples the right to marry. CAMFT firmly believes that all couples and all families, regardless of sexual orientation or gender identity, should have the civil right to marry, with all the associated privileges and responsibilities.
An illuminating study compares the willingness of stage IV cancer patients, and their caregivers; to pay to extend their lives by one year against that of other end-of-life improvements.
Aptus Endosystems, Inc., a medical device company developing advanced technology for endovascular aneurysm repair (EVAR), announced today that it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the Aptus EndoStapling System, which will now be known as the HeliFX™ Aortic Securement System.
Fluxion Biosciences, Inc. announced today that a lawsuit alleging patent infringement had been filed against it in the US District Court of Northern California by Cellectricon AB, its competitor in the field of automated ion channel screening systems for drug discovery. Cellectricon has asserted U.S. Patents Nos. 7,390,650, 7,470,518, and 7,563,614 in the litigation, as well as U.S. Patent No. 5,376,252, which is owned by Gyros and licensed to Cellectricon.
› Verified 3 days ago
Jennifer Bracken Imbriale, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 3401 N Broad St Fl 7, Philadelphia, PA 19140 Phone: 215-707-3187 | |
Dr. Gabriela Isabel Gaudier-alemany, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 5501 Old York Rd, Philadelphia, PA 19141 Phone: 215-456-8220 | |
Dr. Thomas A. Klein, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 834 Chestnut St, Suite 300, Philadelphia, PA 19107 Phone: 215-955-5000 Fax: 215-923-1089 | |
Abike T James, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3400 Spruce St, 5 Penn Tower, Philadelphia, PA 19104 Phone: 215-662-6035 | |
Mathew N Beshara, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 3400 Spruce Street, 5 Penn Tower, Philadelphia, PA 19104 Phone: 215-662-6035 Fax: 215-349-5228 | |
Bernadette C Wheeler, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3400 Spruce Street, 1 West Gates, Philadelphia, PA 19104 Phone: 215-662-2730 Fax: 215-349-5224 | |
Deborah Schiller Schrager, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3998 Red Lion Rd, Suite 106, Philadelphia, PA 19114 Phone: 215-612-4143 Fax: 215-612-4909 |